Form D · Biotechnology
Tetrous, Inc.
Sherman Oaks, CA · CIK 0002002357
Offering snapshot reported Apr 22, 2026 · SEC filing
- Reported sold
- $1.74M Offering amount: $4M
- Investors reported
- 64 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 22, 2026 | Initial | $1,741,024 | No comparison | 64 | SEC filing |
| Dec 22, 2023 | Amendment | $444,639 | $0vs Dec 21, 2023 | 2 | SEC filing |
| Dec 21, 2023 | Initial | $444,639 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-581356
Source: Form D, filed Apr 22, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gunnar Andersson | Director |
| Simon Berry | Director |
| John Bojanowski | Director |
| Andy Carter | Director |
| Jan Iwanczyk | Director |
| Matthew Muscio | Director |
| Bradley E. Patt | Director, Executive |
| Frank Philips | Director |
| Frank Phillips | Director |
| Nikhil Verma | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14930 Ventura Blvd., Suite 325
Sherman Oaks, CA, 91324
Sherman Oaks, CA, 91324